Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03494504
Recruitment Status : Completed
First Posted : April 11, 2018
Last Update Posted : November 6, 2019
Information provided by (Responsible Party):
Aldeyra Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 5, 2018
Actual Study Completion Date : November 5, 2018
Certification/Extension First Submitted : October 30, 2019